Arcuro Medical received FDA 510(k) clearance to market its SuperBall™ all-suture meniscus repair system for the knee.
The company has submitted patent applications in China, Israel, Europe and the U.S., and was recently granted a patent in the U.S.
Arcuro is a TrendLines portfolio company. Its approach is based on a technique in which the entire procedure is performed inside the joint space using suture material only and requiring just one entry into the joint. The proprietary SuperBall repair system comprises a knotless all-suture anchor and delivery system.
Arcuro Medical received FDA 510(k) clearance to market its SuperBall™ all-suture meniscus repair system for the knee.
The company has submitted patent applications in China, Israel, Europe and the U.S., and was recently granted a patent in the U.S.
Arcuro is a TrendLines portfolio company. Its approach is based on a technique in which the...
Arcuro Medical received FDA 510(k) clearance to market its SuperBall™ all-suture meniscus repair system for the knee.
The company has submitted patent applications in China, Israel, Europe and the U.S., and was recently granted a patent in the U.S.
Arcuro is a TrendLines portfolio company. Its approach is based on a technique in which the entire procedure is performed inside the joint space using suture material only and requiring just one entry into the joint. The proprietary SuperBall repair system comprises a knotless all-suture anchor and delivery system.
Copy to clipboard 
